Impai men o Mine aloco icoid Recep o (MR)-dependen
Biological Response by Oxida i e S ess and Aging
CORRELATION WITH POST-TRANSLATIONAL MODIFICATION OF MR AND DECREASED
ADP-RIBOSYLATABLE LEVEL OF ELONGATION FACTOR 2 IN KIDNEY CELLS*
Recei ed o publica ion, Oc obe 2, 2001 and in e ised o m, Decembe 18, 2001
Published, JBC Pape s in P ess, Janua y 23, 2002, DOI 10.1074/jbc.M109530200
G aciela Piwien-Pilipuk‡, An onio Ayala§, Albe o Machado§, and Ma io D. Galigniana‡¶
F om he ‡Depa amen o de Quı´mica Biolo´gica, Facul ad de Ciencias Exac as y Na u ales, Uni e sidad de Buenos Ai es,
Ciudad Uni e si a ia, 1428 Buenos Ai es, A gen ina and he §Depa amen o de Bioquı´mica, B oma ologı´a y Toxicologı´a,
Facul ad de Fa macia, Uni e sidad de Se illa, 41012 Se illa, Spain
Acu e and ch onic ea men s o mice wi h he glu a-
hione-deple ing agen , L-bu hionine-(SR)-sul oximine
(BSO), impai ed he mine aloco icoid ecep o (MR)-
dependen biological esponse by inhibi ing aldos e -
one binding. This s e oid-binding inhibi ion was ully
e e sed when educing agen s we e added o kidney
cy osol ob ained om mice ea ed o 5 h, bu i was
only pa ially e e sed in cy osol ob ained om mice
ea ed o 10 days. Al hough he oligome ic s uc u e o
he MR-hsp90 he e ocomplex was always una ec ed, a
dec eased amoun o MR p o ein was e idenced a e
he long e m ea men . Such a dele e ious e ec was
co ela ed wi h a pos - ansla ional modi ica ion o MR,
as demons a ed by an inc eased le el o ecep o ca -
bonyla ion. In addi ion, a ailu e a he elonga ion/ e -
mina ion s ep was also obse ed du ing he ecep o
ansla ion p ocess in a e iculocy e lysa e sys em.
Thus, a high poly ibosomes/monome s a io and bo h
inc eased p o eolysis and dec eased ADP- ibosyla able
concen a ion o elonga ion ac o 2 (EF-2) we e shown.
Impo an ly, simila obse a ions we e also pe o med
in i o a e deple ion o glu a hione. No wi hs anding
he EF-2 unc ional dis up ion, no all enal p o eins
we e equally a ec ed as he MR. In e es ingly, bo h
EF-2 and MR exp essed in old mice we e simila ly a -
ec ed as in L-bu hionine-(SR)-sul oximine- ea ed
young mice. We he e o e p opose ha a d ama ic de-
ple ion o glu a hione in kidney cells mimics he cumu-
la i e e ec o aging which, a he end, may lead o a
enal mine aloco icoid dys unc ion.
The biological e ec s o aldos e one (ALDO)
1
a e media ed
by he mine aloco icoid ecep o (MR), a ligand-dependen
ansc ip ion ac o ha belongs o he s e oid ecep o class o
nuclea ecep o s. The ansc ip ional ac i a ion o he MR in
epi helial cells igge s a se ies o e en s ha a e esponsible
o he egula ion o he in e nal medium, i.e. Na
⫹
and H
2
O
e en ion and K
⫹
and H
⫹
elimina ion.
S e oid ecep o s exis as nuclea o cy oplasmic he e ocom-
plexes associa ed o he 90-kDa hea shock p o ein (hsp90)
chape one sys em (1, 2). Rega dless o i s subcellula localiza-
ion, his associa ion s abilizes he ecep o in i s ho mone
binding and ansc ip ionally inac i e o m. I is hough ha
upon ligand binding, he s e oid ecep o s unde go a con o ma-
ional change ha leads o he dissocia ion o he hsp90-he -
e ocomplex, dephospho yla ion, dime iza ion, ansloca ion
in o he nucleus ( o cy oplasmic ecep o s), hype phospho y-
la ion, and binding o speci ic ho mone- esponsi e elemen s.
None heless, he ac ual empo al sequence o his cascade o
e en s emains unclea . In con adic ion o wha was p e i-
ously hough , i has been shown ha he dissocia ion o he
hsp90-he e ocomplex upon s e oid binding is no necessa ily
he i s s ep in he signaling pa hway (3, 4). Consis en wi h
his obse a ion, i has also been pos ula ed ha he ecep o -
hsp90 complex equi es in ac cy oskele al acks o mo e e i-
cien ly owa d he nucleus (5). Fo his ansloca ion p ocess,
he ac i i y o he Se /Th phospha ases seems o play a key
ole (3, 6, 7), and cy oplasmic dynein may be he mo o p o ein
equi ed o mo e he complex on he ilamen s (8, 9).
In e es ingly, he MR nuclea ansloca ion is ab oga ed by
oxida i e s ess in in ac kidney cells (2). Se e al s udies (10–
13) pe o med in i o wi h bo h cell- ee sys ems and cells in
cul u e ha e demons a ed ha cys eine g oups on he MR
play an essen ial ole in s e oid binding. We ha e ecen ly
p o ided di ec e idence (14) ha he MR unc ion is also
a ec ed in i o in a simila manne as shown in i o. Thus,
inhibi ion o ALDO binding o enal MR was obse ed a e
adminis e ing mice a ansi ion s a e inhibi o o
␥
-glu amyl-
cys eine syn he ase, L-bu hionine-(SR)-sul oximine (BSO). The
consequen GSH de iciency pa alleled he inhibi ion o he
mine aloco icoid biological esponses o he same ex en a e
bo h sho (5 h) and long (5 days) pe iods o ea men . We
demons a ed ha his e ec was due o he inhibi ion o he
s e oid binding o MR due o oxida ion o essen ial cys eine
g oups a he han changes on he ecep o p o ein concen a-
ion. Howe e , we subsequen ly obse ed ha he le el o ex-
p ession o enal MR is sys ema ically dec eased a e GSH
deple ion o longe imes (i.e. 10 days). Inasmuch as a wide
a ie y o enal diso de s in ol e he o e p oduc ion o eac i e
oxygen species (15–17), a dec eased le el o MR exp ession may
be ele an o unde s and he egula ion o he c i ical acid
* This wo k was suppo ed by g an s om Consejo Nacional de In-
es igaciones Cien ı´ icas y Te´cnicas de la Repu´blica A gen ina and
Minis e io de Sanidad y Consumo de Espan˜a G an FIS 96-1442. The
cos s o publica ion o his a icle we e de ayed in pa by he paymen
o page cha ges. This a icle mus he e o e be he eby ma ked “ad e -
isemen ” in acco dance wi h 18 U.S.C. Sec ion 1734 solely o indica e
his ac .
¶To whom co espondence should be add essed: 1301 Medical Sci-
ence Resea ch Bldg. III, Dep . o Pha macology, he Uni e si y o Mich-
igan Medical School, Ann A bo , MI 48109. Tel.: 734-764-5414; Fax:
734-763-4450; E-mail: [email p o ec ed].
1
The abb e ia ions used a e: ALDO, aldos e one; MR, mine aloco -
icoid ecep o ; hsp90, 90-kDa hea shock p o ein; BSO, L- bu hionine-
(SR)-sul oximine; CH, cumene hyd ope oxide; GSH, educed glu a hi-
one; GME, glu a hione monoe hyl es e ; MDA, malondialdehyde; EF-2,
elonga ion ac o 2; P , o al pep ides; Pn, nascen pep ides; DTT, di-
hio h ei ol; MOPS, 4-mo pholinep opanesul onic acid; SGK, se um-
and glucoco icoid-dependen kinase.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 277, No. 14, Issue o Ap il 5, pp. 11896–11903, 2002
© 2002 by The Ame ican Socie y o Biochemis y and Molecula Biology, Inc. P in ed in U.S.A.
This pape is a ailable on line a h p://www.jbc.o g11896
This is an Open Access a icle unde he CC BY license.
base and elec oly e balance unde no mal o pa hological ci -
cums ances (e.g. oxida i e s ess, me al in oxica ions, aging,
e c.).
A p o ound imbalance be ween oxidan s and an ioxidan s
has been ela ed o enal diso de s, om minimal change ne-
ph i ic synd ome o obs uc i e neph opa hy (16, 18). Mo e-
o e , pa ien s wi h end-s age enal ailu e on main enance
hemodialysis a e ch onically exposed o he oxida i e s ess
gene a ed by eac i e oxygen species due o pe dialy ic neu o-
phil ac i a ion (19). Inc eased concen a ion o malondialde-
hyde (MDA) (20), an in e media e p oduc gene a ed by lipid
pe oxida ion, and dec eased le els o GSH (15) we e also ound
in plasma and e y h ocy es o hemodialyzed pa ien s.
Because he MR is no an expo ed p o ein, a dec eased a e
o p o ein syn hesis and/o an inc eased p o ein deg ada ion in
enal cells may explain he obse ed diminu ion o MR le els
unde ch onic oxida i e condi ions. The p oposi ion ha oxy-
gen adical-media ed oxida ion is a ma king s ep in p o ein
u no e is suppo ed by se e al obse a ions ( e iewed in
Re s. 21 and 22 and e e ences he ein) so ha mos o he
s udies we e mainly ocused on p o ein deg ada ion. In ag ee-
men wi h his no ion, i has been demons a ed ecen ly ha
he u no e o oxidized p o eins is enhanced in ib oblas s ia
p o eosomal ac i i y (23). On he o he hand, he molecula
mechanism o p o ein syn hesis ailu e du ing he onse o
oxida i e s ess has no been ex ensi ely s udied and, conse-
quen ly, is no comple ely de ined. Because o his ac and also
because oxidized MR seems o be mo e s able o he mal deg-
ada ion (al hough incapable o bind s e oid) han i s “ educed”
o m (10), we decided o analyze he e ec o oxida i e s ess
gene a ed by GSH deple ion on he indi idual s eps o polypep-
ide syn hesis in kidney. By using he GSH-deple ing agen
BSO as an expe imen al model, we aimed o s udy he exp es-
sion o enal MR, and we co ela ed his p ocess wi h he
elonga ion phase o p o ein syn hesis unde in i o and in i o
condi ions. Because he elonga ion phase only equi es a small
numbe o ac o s as compa ed wi h he ini ia ion s ep, we also
ocused ou analysis on he MR ansla ion p ocess. In pa ic-
ula , we sea ched o pu a i e pos - ansla ional modi ica ions
o elonga ion ac o 2 (EF-2), he main p o ein implica ed in he
elonga ion s ep. Finally, we discuss ou molecula indings
om he pe spec i e o an in eg a ed p ocess ha may ake
place unde no mal and pa hological condi ions.
MATERIALS AND METHODS
Reagen s—[1,2-
3
H]ALDO (50 Ci/mmol), [U-adenosine-
14
C]NAD (850
mCi/mmol), NaB[
3
H]
4
(63 Ci/mmol), [
35
S]me hionine (1,000 Ci/mmol),
L-[3,4-
3
H] aline (55 Ci/mmol), and
125
I-conjuga ed coun e an ibodies
we e om Pe kinElme Li e Sciences. Reduced GSH, GSH monoe hyl
es e (GME), L-bu hionine-(SR)-sul oximine (BSO), cumene hyd ope -
oxide (CH), p o ein A-Sepha ose, bu yla ed hyd oxyanisole,
␣
- ocoph-
e ol, de e oxamine, manni ol, cys eine, sodium asco ba e, ca alase om
bo ine li e , and diph he ia oxin om Co ynebac e ium diph he iae
we e om Sigma. RU486 was a kind gi om Roussell-Ucla (Romain-
ille, F ance). Comple e-Mini
TM
p o ease inhibi o mix u e was om
Roche Molecula Biochemicals. DNA encoding o ull-leng h human
MR was gene ously p o ided by D . R. E ans (24). TNT Quick-coupled
T ansc ip ion-T ansla ion ki was om P omega Co p. (Madison, WI).
Rabbi polyclonal an ibodies agains EF-2 (25) and he MR (26) we e
desc ibed p e iously. The mouse monoclonal IgG an ibody agains
hsp90 was pu chased om S essGen (Vic o ia, B i ish Columbia, Can-
ada). Donkey an i- abbi and goa an i-mouse IgG-ho se adish pe oxi-
dase an ibodies we e om Pie ce. Chemiluminescence eagen s we e
pu chased om Ame sham Biosciences.
Deple ion o GSH—BSO was dissol ed in e hanol/p opylene glycol/
saline solu ion (3:5:32). Two daily in amuscula injec ions o 2.5 mmol
BSO/kg we e gi en o BALB/c mice (see below) a in e als o 12 h (8:00
and 20:00 h) du ing he indica ed imes. In co- ea men s wi h GME,
h ee doses o 2.0 mmol/kg o he es e we e also injec ed (8:00, 14:00,
and 20:00 h). The ALDO-dependen sodium e en ion and po assium
elimina ion we e measu ed in u ine samples collec ed as desc ibed
p e iously (14, 27).
S e oid Binding Assays—Thi y-day-old and 18-mon h-old male
BALB/c mice we e ad enalec omized by do sal app oach and main-
ained wi h Pu ina Die 1, saline solu ion supplemen ed wi h 50
␮
g/ml
dexame hasone, and eshwa e ad libi um. Two days be o e sac i ice,
he s e oid was omi ed om he saline solu ion, and ood was emo ed
he p e ious nigh . Kidneys we e excised a e ex ensi e pe usion wi h
ice-cold phospha e saline solu ion, and enal co ex-medulla in e -
phases we e homogenized in 1 olume o bu e MOPS/Mo (20 mM
MOPS, 5 mMEDTA, 2 mMEGTA, 10% glyce ol, 2 mMDTT, 20 mM
Na
2
MO
4
, a pH 7.5) con aining 1 able o p o ease inhibi o mix u e
pe 5 ml o solu ion. Homogena es we e cen i uged a 67,000 ⫻g o 45
min a 3 °C, and he supe na an o his cen i uga ion was e e ed o
as cy osol. Renal cy osol was incuba ed o 12 h a 0 °C wi h 20 nM
[
3
H]ALDO and 1.0
␮
MRU486 o mask he sligh c oss- eac ion o ALDO
wi h he glucoco icoid ecep o . A 500- old excess o adioine ALDO
was used o de e mine he nonspeci ic binding (20% o he o al). Bound
s e oid was sepa a ed om ee s e oid by adding 1 olume o 2%
cha coal, 0.2% dex an 15–20. ALDO binding o kidney MR was meas-
u ed in i o as desc ibed be o e (14, 28). B ie ly, 30-day-old male mice
we e ea ed wi h ehicle, BSO, o BSO and GME o he indica ed
pe iods. An in ape i oneal injec ion o 10
␮
Ci o [
3
H]ALDO and 20
␮
g
o RU486 (⫾30
␮
g ALDO) was gi en. Kidneys we e emo ed a e 20
min and homogenized in bu e MOPS/Mo lacking DTT. F ee [
3
H]ALDO
was clea ed om cy osol by adso p ion wi h cha coal/dex an, and he
samples we e di ided in o equal ac ions. The speci ic binding was
measu ed ei he wi hou u he ea men o a e eincuba ing cy-
osol wi h 10 nM[
3
H]ALDO (⫾500- old ALDO) o 3ha 0°Cin he
absence o p esence o 2 mMDTT. F ee ace was adso bed wi h
cha coal, and he adioac i i y was measu ed.
Renal Poly ibosomal P o iles—Poly ibosomes and monome ic ibo-
somes we e analyzed in pos -mi ochond ial supe na an s ea ed wi h
deoxychola e (⬃65% o he o al enal RNA) by using a 20–40% linea
suc ose g adien as desc ibed p e iously (25). The RNA p o iles we e
moni o ed by measu ing he abso bance a 260 nm and hen semi-
quan i ied by planime y.
Inco po a ion o [
3
H]Valine in o To al and Nascen Polypep ide
Chains—The p ocedu e o he de e mina ion o o al p o eins was
simila o he one desc ibed p e iously (25) o li e . Mice we e anes-
he ized wi h pen oba bi al (50 mg/kg); he abdomen was opened, and
25
␮
Ci o L-[3,4-
3
H] aline in 200
␮
l o saline solu ion was injec ed in he
enal a e y. Tissue samples we e aken a he indica ed imes and
immedia ely ozen unde liquid ni ogen un il homogeniza ion in 3
olumes o 0.3 Msuc ose. Unde hese expe imen al condi ions, he
adioac i i y was de ec ed in kidney wi hin 5–10 s a e he injec ion o
adioac i e aline and con inued a an app oxima ely linea a e o
2.5–3.0 min. The e o e, we began o ob ain issue samples 20 s a e he
injec ion and du ing a o al pe iod o 2 min. Kidney homogena es in 0.3
Msuc ose we e dilu ed wi h 1 olume o a bu e con aining 100 mMT is
and2mMmagnesium ace a e and cen i uged o 15 min a 4,000 ⫻g.
Two ml o he supe na an we e mixed wi h 0.2 ml o 20% sodium
deoxychola e, incuba ed on ice o 30 min, and hen cen i uged a
8,000 ⫻g o 15 min. P o eins in he esul an supe na an we e used
o quan i y o al and nascen chains. To measu e adioac i i y o o al
enal p o ein, an aliquo o his supe na an was ea ed wi h 10%
ichlo oace ic acid a 90 °C o 1.5 h. P ecipi a ed p o eins we e edis-
sol ed wi h p o osol, and he adioac i i y was coun ed. The inco po a-
ion o labeled aline in o nascen polypep ides was de e mined laye -
ing 1.5 ml o supe na an on 6 ml o a medium con aining 1 Msuc ose,
1mMmagnesium ace a e, and 1 ml o a 100,000 ⫻gsupe na an
ob ained by 1 h o ul acen i uga ion o kidney homogena e (1:2) in 50
mM ie hanolamine, 5 mMMgCl
2
,25mMKCl and 0.25 Msuc ose (pH
7.3). The mix u e was cen i uged a 25,000 ⫻g, and he esul an
pelle was esuspended in 1 ml o dis illed wa e . P o eins we e p ecip-
i a ed and he adioac i i y coun ed as desc ibed abo e.
Immunop ecipi a ion o MR—We ollowed a s anda d echnique as
desc ibed p e iously (3, 14). B ie ly, enal cy osol was incuba ed wi h
he abbi an i-MR immune se um (o non-immune abbi se um) p e-
bound o p o ein A-Sepha ose and washed ou imes wi h ice-cold
MOPS bu e supplemen ed wi h 100 mMNaCl and 0.01% Nonide
P-40, and MR and hsp90 we e iden i ied by Wes e n blo analysis.
In Vi o T ansc ip ion and T ansla ion o he MR—The p ocedu e
was pe o med using he TNT Quick-coupled T ansc ip ion/T ansla ion
ki om P omega Co p. (Madison, WI) acco ding o he manu ac u e ’s
ins uc ions. Recombinan phMR3750 DNA encoding o ull-leng h
human MR (24) inse ed in o polylinke EcoRI si e o pGEM4 (P omega
Bio ech) was used as a empla e o ansc ip ion wi h T7 polyme ase
MR Inac i a ion by Oxida i e S ess 11897
ollowed by ansla ion in he p esence o [
35
S]me hionine. P o eins
we e esol ed by SDS-PAGE and au o adiog aphed. When he incuba-
ions we e pe o med in he p esence o oxidan s, he e iculocy e lysa e
was p eincuba ed o 60 min a 25 °C wi h ei he 2.0 mMCH and/o 5.0
mMBSO. In he p o ec ion assays agains oxidan s, a educing solu ion
was also simul aneously added o he medium a he ollowing inal
concen a ions: 20
␮
Mbu yla ed hyd oxyanisole, 200
␮
M
␣
- ocophe ol, 5
mMGSH, 5 mMcys eine, 2 mMDTT, 1 mMsodium asco ba e, 20 mM
manni ol, 3 mMde e oxamine, and 0.5 mg/ml ca alase.
ADP- ibosyla ion o EF-2—ADP- ibosyla ion was pe o med by a
modi ica ion o he me hod used by Galicka e al. (29). Renal EF-2 was
immunop ecipi a ed om enal cy osol wi h he abbi polyclonal an i-
body aised agains EF-2 p ecoupled o p o ein A-Sepha ose. The im-
mune pelle was washed wice wi h MOPS bu e con aining 100 mM
NaCl and 0.01% Nonide P-40 and wice wi h 20 mMT is bu e a pH
7.4. The pelle s we e incuba ed o 1ha 37°C wi h 50
␮
l o a solu ion
con aining 20 mMT is, 10 mMDTT, 10
␮
M[
14
C]NAD, and 5
␮
go
diph he ia oxin. The pelle s we e washed ou imes wi h 1 ml o 20 mM
T is bu e , and he adioac i i y inco po a ed o he immunopu i ied
EF-2 was coun ed.
Pu i ica ion o EF-2—EF-2 was isola ed om he ibosome- ee ex-
ac o abbi e iculocy e lysa e as desc ibed by Ryazano and Da y-
do a (30). The pu i y o he inal p epa a ion was e i ied by SDS-
PAGE ollowed by Coomassie Blue G-250 s aining and pa allel Wes e n
blo ing wi h an i-EF-2 an ibody. The a e o inco po a ion o [
35
S]Me
o hMR in abbi e iculocy e lysa e sys em supplemen ed wi h pu e
EF-2 was measu ed a e alkaline hyd olysis ollowed by ichlo oace ic
acid p ecipi a ion as desc ibed p e iously (31).
Miscellaneous—Renal GSH concen a ion was quan i ied by an en-
zyma ic assay as desc ibed p e iously (14). Ca bonyl con en in ei he
enal mic osomes o immunopu i ied p o eins was measu ed by educ-
ion wi h i ia ed sodium bo ohyd ide acco ding o Lenz e al. (32).
MDA was measu ed wi h he hioba bi u ic s anda d me hod desc ibed
by Es ebaue and Cheeseman (33). S a is ical es s we e ca ied ou by
analysis o a iance ollowed by Bon e oni analysis.
RESULTS
E ec o GSH Deple ion on he Mine aloco icoid Response—
Table I shows ha he enal concen a ion o GSH was d a-
ma ically dec eased when mice we e ea ed wi h he
␥
-glu-
amylcys eine syn he ase inhibi o , BSO. Such an e icien
deple ion was achie ed as soon as 5 h a e a single injec ion o
BSO. On he o he hand, a co- ea men wi h he cell-pe me-
able es e GME ully p e en ed he dele e ious e ec o BSO by
p ese ing (and e en inc easing) he in acellula le els o
GSH. In ag eemen wi h he onse o an oxida i e in acellula
milieu, an inc eased concen a ion o bo h MDA, a p oduc
gene a ed by he b eak down o hyd ope oxides, and p o ein
ca bonyls we e also measu ed a e acu e (5 h) and p olonged
(3 and 10 days) ea men . On he o he hand, he le els o
hese wo ma ke s o oxida ion we e indis inguishable om
un ea ed con ols when mice we e co- ea ed wi h BSO and
GME.
To e alua e he in i o mine aloco icoid e ec , a sa u a ing
dose (28) o 2
␮
g o ALDO pe 100 g o body weigh was injec ed,
and he an i-na iu e ic and kaliu e ic e ec s we e measu ed.
ALDO dec eased he Na
⫹
/K
⫹
u ina y a io by 80% in con ol
ad enalec omized mice. Howe e , he biological esponse o
ALDO was a enua ed a e 5ho BSOinjec ion, so a 2.5- old
highe Na
⫹
/K
⫹
a io was measu ed. This e ec was mo e sig-
ni ican o longe pe iods o ea men (3 and 10 days). Taken
oge he , hese esul s clea ly con i m (14) ha he deple ion o
enal GSH impai s he mine aloco icoid biological esponse.
In e es ingly, he da a shown in Table I also sugges a simila
e ec o aging on he mine aloco icoid esponse. Thus, 18-
mon h-old animals also exhibi high le els o p o ein ca bonyls
and MDA, as well as a dec eased biological esponse o ALDO
as compa ed wi h 30-day-old animals.
In Vi o [
3
H]ALDO Binding Assay—To e alua e he MR bind-
ing capaci y in i o, con ol and BSO- ea ed mice we e in-
jec ed wi h [
3
H]ALDO, and kidneys we e excised a e 20 min,
a ime when enal adioac i i y eaches a maximum le el in
kidney (28). Renal cy osol was ob ained in MOPS/Mo bu e
wi hou DTT; ee ace was clea ed by adso p ion wi h cha -
coal/dex an, and he samples we e di ided in o equal ac-
ions. The speci ic binding (Fig. 1) was measu ed ei he wi hou
u he ea men o a e a eincuba ion o cy osols wi h
[
3
H]ALDO in he absence o p esence o 2 mMDTT. As ex-
pec ed, he ea men wi h BSO dec eased he s e oid binding
capaci y o MR unde in i o condi ions, whe eas his inhibi-
ion was ully p e en ed by co- ea men wi h GME. When
adiolabeled cy osols we e eincuba ed in i o wi h [
3
H]ALDO,
he speci ic binding emained unchanged (g ay ba s), indica -
ing ha he in i o ALDO labeling had sa u a ed he MR
binding capaci y. Consis en wi h he no ion ha an oxida i e
milieu inhibi s he s e oid binding capaci y o MR by oxida ion
o essen ial cys eine g oups, eincuba ion o hese cy osols in
he p esence o DTT eco e ed he speci ic binding o cy osolic
MR ob ained om BSO- ea ed mice (black ba s). Impo an ly,
such eco e ing was o al in mice ea ed o 5 h, bu i was only
pa ial in cy osols ob ained om mice ea ed wi h BSO o 3
and 10 days. Thus, ⬃20 and 35% o he MR s e oid binding
capaci y was no eco e ed, espec i ely. Again, old mice ex-
TABLE I
Oxida i e s ess ab oga es he mine aloco icoid biological e ec
Ad enalec omized 30-day-old o 18-mon h-old mice we e ea ed wi h BSO o BSO and GME o he indica ed imes. Con ols we e ea ed wi h
ehicle only. The mine aloco icoid e ec (Na
⫹
/K
⫹
a io) was measu ed in i o a e injec ing a sa u a ing dose o ALDO as desc ibed unde
“Ma e ials and Me hods.”Con en s o GSH in enal cy osol and MDA and CO we e also quan i ied in mic osomal ac ions. Resul s a e he mean ⫾
S.E. (n⫽6).
Condi ion Renal GSH
a
MDA
b
CO
b
Na
⫹
/K
⫹
a io
c
30-day-old mice 2.51 ⫾0.21 16.1 ⫾2.9 351.3 ⫾33.1 0.17 ⫾0.04
BSO
5 h 0.34 ⫾0.15
d
37.5 ⫾9.3
e
544.4 ⫾22.7
d
0.44 ⫾0.10
d
3 days 0.18 ⫾0.06
d
40.1 ⫾1.8
d
635.9 ⫾21.9
d
0.50 ⫾0.11
d
10 days 0.15 ⫾0.08
d
61.4 ⫾1.9
d
729.6 ⫾45.0
d
0.58 ⫾0.05
d
BSO ⫹GME
5 h 2.75 ⫾0.14 18.1 ⫾3.0 370.7 ⫾20.8 0.15 ⫾0.02
3 days 4.04 ⫾0.61
e
14.4 ⫾1.2 318.0 ⫾13.1 0.19 ⫾0.09
10 days 4.62 ⫾1.01
e
13.7 ⫾3.1 304.1 ⫾21.2 0.21 ⫾0.12
18-Mon h-old mice 1.87 ⫾0.45
e
36.0 ⫾4.2
d
608.3 ⫾32.1
d
0.37 ⫾0.03
d
a
Values a e gi en in
␮
mol/g o enal issue.
b
Values a e gi en in mmol/mg o mic osomal p o ein.
c
The Na
⫹
/K
⫹
a io in con ol mice was 1.27 ⫾0.14.
d
Values di e en om con ol (30-day-old mice) a p⬍0.001.
e
Values di e en om con ol a p⬍0.010.
MR Inac i a ion by Oxida i e S ess11898
hibi ed simila p ope ies as hose shown by long e m BSO-
ea ed young mice.
Associa ion o MR wi h hsp90—Because he associa ion o
hsp90 wi h MR is an absolu e equi emen o bind s e oid, we
analyzed he co-immunopu i ica ion o hsp90 wi h enal MR
a e ea men wi h BSO. The ba g aph in Fig. 2 depic s he
ALDO binding capaci y measu ed in i o in cy osols ob ained
om con ol and ea ed mice, because hese expe imen al
esul s a e simila o hose shown in Fig. 1 unde in i o
condi ions. Mo eo e , a cons an hsp90/MR op ical densi y a-
io (0.19 ⫾0.02) was ob ained o all he Wes e n blo s shown
a he op o Fig. 2 a e a densi ome ic scanning. These
co-immunop ecipi a ion assays demons a e ha oxida i e
s ess does no dec ease he MR binding capaci y by dis up ing
he associa ion o MR wi h he chape one complex. Howe e ,
he amoun o MR (and hence, hsp90) eco e ed in he he e o-
complex a e 10 days o ea men wi h BSO (condi ion 5) was
one- hi d lowe han he amoun o MR p o ein eco e ed om
ei he con ol cy osol (condi ion 2), cy osols om BSO- ea ed
mice (condi ions 3 and 4), o GME- and BSO- ea ed mice
(condi ion 6). These esul s demons a e ha he dec eased
s e oid binding capaci y o MR measu ed in enal issue was
due o a lowe concen a ion o MR a he han an oxida i e
dis up ion o he MR-hsp90 in e ac ion. Wes e n blo analysis
o o al cy osol esol ed by SDS-PAGE (shown below he ba
g aph) e idenced ha he cy osolic hsp90 concen a ion was
g ea ly inc eased due o he onse o oxida i e s ess, and such
induc ion was ully p e en ed by co- ea men wi h GME (con-
di ion 6). A Wes e n blo o
␤
- ubulin was also pe o med in
he same samples, and no change was e idenced o his essen-
ial cy oskele al p o ein.
Impo an ly, Fig. 2 also demons a es ha all he ea u es
obse ed in ch onically s essed young mice we e also p esen
in un ea ed old mice (compa e condi ions 5 and 7), ein o cing
he simila i ies poin ed ou be o e be ween oxida i e s ess and
na u al aging.
In Vi o T ansc ip ion and T ansla ion o Human MR—The
dec eased concen a ion o MR ob ained by ch onic oxida i e
s ess can be due o ecep o deg ada ion o a less e icien
ecep o syn hesis. The e a e e idences in a o o bo h possi-
bili ies. Thus, i is known ha adically media ed damaged
p o eins a e o en unc ionally inac i e, and hei un olding
was associa ed wi h enhanced suscep ibili y o p o eases (22).
Howe e , we ha e epo ed p e iously (10) ha he oxidized
MR p o ein, al hough incapable o bind s e oid, seems o be
qui e s able as compa ed wi h i s educed coun e pa . Mo e-
o e , ecen e idence suppo s he no ion ha p o ein syn he-
sis may decline unde oxida i e condi ions by changes in he
polypep ide elonga ion a e (34, 35). The e o e, we ocused ou
s udy on he a ious s eps o p o ein syn hesis unde oxida i e
condi ions.
We i s analyzed he exp ession o a DNA empla e encoding
o human MR by using he abbi e iculocy e in i o an-
sc ip ion/ ansla ion sys em. A main
35
S-labeled p oduc can
be seen as a 110-kDa band in Fig. 3A, as his molecula weigh
is compa ible wi h he size o human MR (24). Impo an ly, his
110-kDa band was also e ealed by Wes e n blo wi h he
an i-MR an ibody (da a no shown). P eincuba ion o e iculo-
cy e lysa e wi h BSO ailed in a ec ing he MR ansla ion in
a signi ican o m (Fig. 3A, compa e lane 2 e sus 1). In pa ,
his ailu e may be due o he mechanism o ac ion o he
ansi ion s a e enzyma ic inhibi o . In e ec , BSO is p esen
in a pos -mi ochond ial medium ha lacks an e icien sou ce
o pe oxide adical p oduc s gene a ed du ing, o example, an
ac i e oxida i e me abolism. Then he simple inhibi ion o he
GSH syn hesis unde hese in i o condi ions may no be
su icien o a ec signi ican ly he ansla ion machine y.
Tha his may be he case is suppo ed by he signi ican
inhibi ion o MR exp ession achie ed wi h cumene hyd ope -
oxide (CH) (Fig. 3A,lane 3), a known gene a o o eac i e
oxygen in e media es (25, 36, 37), and also because o he
po en ia ion ob ained when bo h agen s, BSO and CH, we e
used oge he (Fig. 3A,lane 5). As expec ed o a adically
media ed e ec , he CH-dependen inhibi ion o MR syn hesis
was abolished when he lysa e was p eincuba ed wi h CH in
he p esence o a educing mix u e (Fig. 3A,lane 4) con aining
20
␮
Mbu yla ed hyd oxyanisole, 200
␮
M
␣
- ocophe ol, 5 mM
GSH, 5 mMcys eine, 2 mMDTT, 1 mMsodium asco ba e, 20 mM
manni ol, 3 mMde e oxamine, and 0.5 mg/ml ca alase. Inas-
much as he syn hesis o MR was pe o med in i o, wo s eps
a e hen equi ed o comple e he p ocess, empla e ansc ip-
ion ollowed by ansla ion. I could be possible ha a de-
c eased p oduc ion o MR may be due o a ailu e in he o me
p ocess a he han in he ansla ion s ep. The e o e, we pe -
FIG.1.In i o ALDO binding o kidney MR. Thi y-day-old male
mice we e ea ed wi h ehicle (con ol), BSO, o BSO and GME o he
imes indica ed below he g aphs. Then an in ape i oneal injec ion o
10
␮
Ci o [
3
H]ALDO and 20
␮
g o RU486 (⫾30
␮
g ALDO) was gi en.
Kidneys we e emo ed a e 20 min and homogenized in a bu e lack-
ing DTT. F ee [
3
H]ALDO was clea ed by adso p ion wi h cha coal/
dex an, and he samples we e di ided in o equal ac ions. The speci ic
binding was measu ed ei he wi hou u he ea men (whi e ba s)o
a e a eincuba ion o he cy osol o 3ha 0°C wi h 10 nM[
3
H]ALDO
(⫾500- old ALDO) in he absence (g ay ba s) o p esence (black ba s)o
2m
MDTT. The ALDO binding capaci y measu ed in i o in 18-mon h-
old mice is also shown (old mice). Resul s ep esen he means ⫾S.E. o
ou animals pe g oup. Di e en om con ols a *,p⬍0.001; **, p⬍
0.005; and ***, p⬍0.010.
FIG.2. Co-immunop ecipi a ion o hsp90 wi h he MR. Mice
we e ea ed wi h BSO alone o co- ea ed wi h BSO and GME o he
indica ed imes. Kidney cy osol was hen ob ained, and he MR was
immunop ecipi a ed. A Wes e n blo o MR and co-immunop ecipi-
a ed hsp90 is shown a he op o he igu e. An aliquo o his cy osol
was used o pe o m a s e oid binding assay (ba g aph) and depic ed as
he means ⫾S.E. (n⫽4). A second aliquo o cy osol was Wes e n-
blo ed o hsp90 and
␤
- ubulin (shown on he bo om o he g aphic).
Condi ions a e as ollows. 1, Non-immune pelle was ob ained by incu-
ba ion o con ol cy osol wi h a p eimmune abbi IgG an ibody. 2,
Con ol cy osol was om un ea ed mice. Cy osol om BSO- ea ed
mice o 5h(3), 3 days (4), and 10 days (5). 6, Cy osol was om mice
co- ea ed wi h BSO and GME o 10 days. 7, Cy osol was om 18-
mon h-old mice. As compa ed wi h condi ion 2, di e ences o speci ic
binding a e signi ican a p⬍0.001 o condi ions 3–5, and p⬍0.005 o
condi ion 7.
MR Inac i a ion by Oxida i e S ess 11899
o med di ec s udies on he ini ia ion and comple ion s eps o
he polypep ide syn hesis by analyzing he poly ibosomal p o-
iles in e iculocy e lysa es unde no mal and oxida i e condi-
ions. A ep esen a i e linea suc ose g adien is depic ed in
Fig. 3B. I shows ha an inc eased ibosomal s a e o agg ega-
ion was ob ained unde oxida i e condi ions. Thus, he poly-
somes/monome s a io was 4- old highe in ea ed lysa es han
in con ol samples (66 e sus 16, espec i ely). The highe
polysomes/monome s a io obse ed in CH- ea ed lysa e is he
consequence o bo h a 2- old inc eased amoun o polysomes
and also a 50% educ ion o he single 80 S ibosome o ms. I
is known ha he cycling be ween single ibosomal subuni s
( o ms no in ol ed in ansla ion) and poly ibosomes is e y
apid (38, 39), and hose ibosomes eleased a chain e mina-
ion may ei he become monome ic ibosomes o may be con-
e ed in o na i e subuni s (31, 40) unless he ini ia ion is
supp essed, in which case accumula ion o single ibosomes
occu s (41–43). The e o e, he esul s shown in Fig. 3Bag ee
wi h he no ion ha he elonga ion/ e mina ion s ep should be
mo e a ec ed by oxida i e s ess han he ini ia ion s ep du -
ing he ansla ion p ocess.
The main p o ein implica ed in he elonga ion s ep is he
EF-2. The e o e, we analyzed he EF-2 le el by Wes e n blo -
ing aliquo s o e iculocy e lysa e incuba ed wi h BSO and CH,
and no di e ences we e obse ed o he o al concen a ion o
EF-2 in any condi ion (da a no shown). I is known ha ADP-
ibosyla ion o a peculia diph hamide esidue p esen on EF-2
abolishes i s abili y o ansloca e he pep idyl- RNA om he
A-si e o he P-si e on he ibosome (44). Fu he mo e, ADP-
ibosyla ion o EF-2 wi h diph he ia oxin and NAD ha e been
used as an indica o o he ac i e EF-2 ac ion (25, 29, 34, 45).
The e o e, we immunopu i ied EF-2 om e iculocy e lysa e
and de e mined he amoun o ac i e p o ein. Fig. 3Cdemon-
s a es ha he amoun o ADP- ibosyla able EF-2 was e-
duced by 50 and 80% in CH- and CH/BSO- ea ed samples
(condi ions 3 and 5, espec i ely). This educed le el o ac i e
EF-2 was no obse ed when he incuba ion was pe o med in
he simul aneous p esence o he educing mix u e. Taken
oge he , he esul s shown in Fig. 3 sugges ha i is en i ely
possible ha he dec eased MR concen a ion obse ed in
GSH-deple ed mice may lie on he inabili y o enal cells o
achie e e icien ly he comple ion o he nascen p o ein, mo e
speci ically due o ans o ma ion o EF-2.
The Addi ion o Pu i ied EF-2 Reco e s he T ansc ip ion o
hMR in Vi o—Gi en he numbe o p o eins ha a e likely o
be modi ied du ing oxida i e s ess, a di ec ole o EF-2 canno
be ensu ed om ou p e ious expe imen s. None heless, i he
damage o EF-2 is one o he easons o he obse ed dec ease
in hMR le els du ing he ansc ip ion, he addi ion o pu i ied
EF-2 o he ansc ip ion/ ansla ion sys em should co ec
such de iciency. The e o e, we i s pu i ied EF-2 om abbi
e iculocy e lysa e and adjus ed he amoun o be added o he
ansla ion medium by compa ison wi h he endogenous le el
o EF-2 p esen in e iculocy e lysa e. The Wes e n blo shown
in Fig. 4Ashows ha 0.3
␮
l o pu i ied EF-2 ( e e ed o as 1⫻)
ma ches he concen a ion o endogenous EF-2 in 5.0
␮
lo
e iculocy e lysa e, so ha we used his ela i e amoun o
EF-2 as a e e ence. We hen supplemen ed he CH- ea ed
e iculocy e lysa e employed as a ansc ip ion/ ansla ion sys-
em wi h pu i ied EF-2. The hMR ansla ion p oduc s a e
shown in Fig. 4B. As can be seen, he inhibi o y e ec o
oxida i e s ess on he hMR ansla ion was p e en ed when
pu i ied EF-2 was added o he incuba ion medium (Fig. 4B,
compa e lane 3 e sus lane 2). On he o he hand, he addi ion
o pu i ied EF-2 p eincuba ed wi h 2 mMCH exhibi ed no e ec
on he le el o exp ession o hMR (Fig. 4B, compa e lanes 4
e sus lane 1).
Fig. 4Cdepic s he a es o syn hesis o hMR measu ed as
inco po a ion o [
35
S]me hionine o he acid-insoluble ac ion.
The a e o syn hesis o
35
S-labeled hMR was g ea ly dec eased
unde oxida i e condi ions, whe eas he addi ion o pu i ied
EF-2 o he medium was able o co ec he ansla ion p ocess
in a concen a ion-dependen manne . In con as , when he
ansla ion mix u e was supplemen ed wi h he same p epa-
a ion o EF-2 ha had been p einac i a ed wi h CH, he
co ec ion o he hMR ansla ion was no obse ed. The pu i-
ied EF-2 p o ein emains s able unde he condi ions used o
he p eincuba ion wi h CH (as judged by SDS-PAGE ollowed
by Coomassie Blue s aining), al hough i s ADP- ibosyla ion by
diph he ia oxin was ully abolished (da a no shown).
Taken oge he , hese esul s clea ly indica e ha EF-2 may
be esponsible o he obse ed dec ease o hMR le el du ing
he ansla ion p ocess unde oxida i e condi ions.
Renal Poly ibosomal P o iles—In iew o he p e ious obse -
a ions, we nex analyzed he polysome p o iles in kidney cy-
osol a e mice we e ea ed wi h BSO. Resul s a e shown in
Fig. 5. Consis en wi h he abo e-desc ibed in i o e ec , Fig.
5Ashows an inc eased ibosomal s a e o agg ega ion when
oxida i e s ess was gene a ed in i o by ea men wi h BSO
o 3 and 10 days (25 and 82% la ge poly ibosome peak,
FIG.3.In i o ansla ion o human MR. A, elec opho e ic analysis o he ansla ed p oduc . The ansc ip ion/ ansla ion sys em was
p e ea ed o 30 min a 25 °C as ollows: lane 1, un ea ed con ol; lane 2,5m
MBSO; lane 3,2mMCH; lane 4,2mMCH and he educing mix u e
desc ibed unde “Ma e ials and Me hods”;lane 5,5m
MBSO and 2 mMCH. The ansla ion eac ion was pe o med in he p esence o
[
35
S]me hionine. P o eins we e esol ed by SDS-PAGEand au o adiog aphed. The a ow shows he band o MR when a Wes e n blo e ealed i .
B, suc ose g adien o abbi e iculocy e ibosomes. Poly ibosomal p o iles om no mal lysa e (solid line) and CH- ea ed lysa e (do ed line) we e
de e mined as desc ibed unde “Ma e ials and Me hods.”The a ow shows he 80 S monome s. C, ADP- ibosyla able concen a ion o EF-2. EF-2
was immunop ecipi a ed om e iculocy e lysa e p e ea ed in he same condi ions as desc ibed o A(lanes 1–5). A Wes e n blo o his
immunop ecipi a ion is shown a he op o he ba g aph o each condi ion. The ac i e concen a ion o EF-2 was measu ed by using a s anda d
eac ion wi h [
14
C]NAD and diph he ia oxin. The ba g aph ep esen s he means ⫾S.E. (n⫽3) o he pe cen age o ac i e EF-2 wi h espec
o he un ea ed lysa e (condi ion 1) s anda dized as 100% (11.3 ⫾1.9 pmol/mg). Condi ions 3 and 5a e signi ican ly di e en om condi ion 1
a p⬍0.001.
MR Inac i a ion by Oxida i e S ess11900

espec i ely). On he o he hand, he poly ibosomal p o ile o
BSO- and GME-co- ea ed mice was indis inguishable om
ha ob ained wi h un ea ed mice (Fig. 5B). In addi ion, he
poly ibosomes/monome s a io was also inc eased in 18-mon h-
old mice (116%), s eng hening he no ion ha aging is a p oc-
ess whe e cumula i e damage by oxida ion a ec s he p o ein
syn hesis machine y.
We hen measu ed he polypep ide chain comple ion ime.
This pa ame e is accep ed as a quan i a i e exp ession o he
a e o pep ide chain elonga ion and e mina ion (25, 34, 46,
47). The adioac i i y inco po a ed in o bo h nascen pep ides
in poly ibosomes (Pn) and o al pep ides (P ) was plo ed
agains he ime a e he injec ion o [
3
H] aline in o he enal
a e y. The alue o Pn o each animal was hen di ided by he
co esponding alue o P , and he Pn/P a io was inally
plo ed agains he ime (Fig. 5C). I i is assumed ha he
adioac i e amino acid will mee he ibosomes in he middle o
he ansla ion o a mRNA o a e age size (25, 46, 47), so he
whole pep ide on he ibosome should be labeled when a ull
cycle is comple ed. In u n, hose chains ha ha e been e mi-
na ed and eleased will be only 50% labeled. A e a second
cycle, 1 ull uni will inc ease he pool o eleased pep ides,
whe eas he Pn/P a io should ha e been educed o 25%.
Thus, he ime equi ed o educe Pn/P om 50 o 25% should
be ep esen a i e o he a e age comple ion ime (elonga ion
and e mina ion s eps). This ime is independen o bo h he
numbe o ibosomes engaged in he p ocess and a ia ions in
he ini ia ion s ep and can be calcula ed di ec ly om he slope
o he unc ion. In ou hands, he a e age comple ion ime
inc eased om 58 o 98 s in mice ea ed wi h BSO o 10 days.
Old mice e idenced a comple ion ime equal o 158 s.
Damage o Renal MR and EF-2—We hen measu ed he
ADP- ibosyla able con en o EF-2 immunopu i ied om kid-
ney cy osol o BSO- ea ed mice. Fig. 6 shows ha he ac i e
amoun o EF-2 was educed nea ly 50% a e 10 days o GSH
deple ion (ha ched ba s). In u n, he p o ein ca bonyl con en
in he immune pelle s was inc eased 2- old (black ba s). Bo h
dele e ious e ec s we e o ally p e en ed by GME. On he
o he hand, he con en o ca bonyls measu ed in MR immu-
nopu i ied om BSO- ea ed mice (whi e ba s) was inc eased
40% wi h espec o un ea ed animals. A simila le el o MR
ca bonyla ion was also measu ed in 18-mon h-old mice.
In he expe imen shown in Fig. 2, we demons a ed ha he
qua e na y s uc u e o he MR-hsp90 he e ocomplex was no
a ec ed by oxida i e s ess. Those Wes e n blo s did no show
lowe molecula mass p o eoly ic agmen s o MR. This obse -
a ion ag ees wi h he esul s shown in Fig. 3Aand hose
desc ibed p e iously (10). On he o he hand, Pa ado e al. (34)
ha e ecen ly epo ed ha a li e EF-2 does unde go ag-
men a ion upon he onse o oxida i e s ess induced by CH. As
a consequence, we s udied he pu a i e agmen a ion o cy o-
solic EF-2 in mouse kidney a e ea men wi h BSO. Fig. 6B
shows he p o ein p o ile ob ained wi h he an i-EF-2 an ibody
in enal cy osol. Thi y-day-old un ea ed mice exhibi ed a
main band o EF-2 a he expec ed molecula mass o 100-kDa
(Fig. 6B,lane 1). Besides his band, cy osol om BSO- ea ed
mice also exhibi ed a majo p o eoly ic agmen a 39 kDa and
wo mino bands a 51 and 67 kDa (lanes 2 and 3). The ull
p e en ion o he EF-2 agmen a ion obse ed in cy osol o
GME co- ea ed mice (lane 4) p o es ha p o eolysis o EF-2 in
i o depends on he onse o oxida i e s ess. Thus, old mice
also exhibi a agmen a ion pa e n o EF-2 simila o ha
gene a ed by he deple ion o GSH in young mice (lane 5).
Howe e , he o al amoun o ull-leng h EF-2 was also signi -
ican ly dec eased in old mice, an obse a ion ha is consis en
wi h he signi ican ly slowe hal - ansi ime o nascen
polypep ides obse ed in Fig. 5C o his g oup o animals.
Diminished EF-2 le els we e also ound in li e o CH- ea ed
a s (34). Cu iously, despi e he lowe ull-leng h EF-2 le el
obse ed o old mice, Fig. 6Balso shows ha he amoun o
p o eoly ic agmen s emained unchanged. This obse a ion
may be ela ed o he inhibi ion o he p o eosome ac i i y
desc ibed in ce ain old cells (23), which in u n leads o he
cyclic accumula ion o damaged and agg ega ed p o eins.
DISCUSSION
In his wo k we demons a ed ha oxida i e s ess impai s
he mine aloco icoid biological esponse by wo di e en mo-
lecula mechanisms. As suppo ed by he expe imen s de-
sc ibed in Table I and Figs. 1 and 2, one o hese inhibi o y
mechanisms in ol es he pos - ansla ional modi ica ion o he
ecep o p o ein by oxida ion. Consis en wi h he esul s e-
po ed in he li e a u e (10–14), i is mos likely ha oxidiza-
ion o essen ial cys eine g oups is he main esponsibili y o
such inhibi ion. In he sho ime (hou s), he inhibi o y e ec
obse ed by deple ion o GSH can be ully e e sed in i o by
incuba ing enal cy osol wi h DTT o can be o ally p e en ed
in i o by co-adminis e ing GME. A second ha m ul mecha-
nism able o a ec he mine aloco icoid esponse was e i-
denced a e se e al days o GSH deple ion, and i a ec ed he
p o ein ansla ion sys em a he elonga ion/ e mina ion s eps.
Because poly ibosomes can be o med in i o (Fig. 3B) and
in i o (Fig. 5, Aand B), and he e was a dec eased numbe
a he han accumula ion o monome s, i is unlikely ha he
ini ia ion s ep can be as s ongly a ec ed as he comple ion
s ep (41–43). In ag eemen wi h he no ion ha he elonga ion/
e mina ion s ep is a ec ed by he onse o oxida i e s ess, he
a e o ansla ion in i o was es o ed a e addi ion o pu i-
ied EF-2 o he incuba ion medium (Fig. 4). Mo eo e , he
hal - ansi a e o nascen polypep ide chains in enal cells is
almos wice as slow in BSO- ea ed mice as in he un ea ed
con ols. The obse ed e ec s on p o ein syn hesis du ing he
BSO-dependen deple ion o enal GSH a e simila o hose
FIG.4. The addi ion o pu i ied EF-2 o e iculocy e lysa e
p e en s he ha m ul e ec o a low edox po en ial medium on
he ansla ion p ocess. A, ela i e amoun o pu i ied EF-2. Va ious
amoun s (0.3, 0.6, and 1.2
␮
l) o he inal p epa a ion o pu i ied EF-2
we e compa ed by Wes e n blo ing wi h he endogenous le el o EF-2
p esen in 5
␮
l o e iculocy e lysa e. The a io 0.3
␮
l o pu e EF-2 o 5
␮
l o e iculocy e lysa e is e e ed o as 1 ime. B, ansla ion o hMR
in e iculocy e lysa e sys em. The ansla ion eac ion was pe o med
as desc ibed o Fig. 3Band au o adiog aphed o he [
35
S]Me -labeled
hMR. Condi ions a e as ollows: 1, un ea ed con ol; 2, lysa e ea ed
wi h 2 mMCH; 3, lysa e ea ed wi h 2 mMCH and supplemen ed wi h
2 imes pu i ied EF-2; 4, lysa e ea ed as in condi ion 3 bu EF-2 was
incuba ed o 1ha 25°Cwi h2m
MCH. C, a e o syn hesis. The
adioac i i y associa ed o he ichlo oace ic acid-insoluble p oduc
was measu ed as a unc ion o he ansla ion ime. Condi ions a e as
ollows: un ea ed con ol (solid ci cles), lysa e ea ed wi h 2 mMCH
(open ci cles), lysa e ea ed wi h CH and supplemen ed wi h EF-2 as
ollows: 1⫻(open squa e), 2⫻(solid squa es,solid line), o 2⫻s o ed o
24 h in a bu e con aining 2 mMCH (solid squa es,do ed line). Resul s
a e he a e age o wo independen expe imen s pe o med by
duplica e.
MR Inac i a ion by Oxida i e S ess 11901
desc ibed in he li e o a s ea ed wi h he adical dono
cumene hyd ope oxide (25, 34). We emphasize ha we we e
unable o gene a e an e icien oxida i e s ess wi h BSO in
adul a s and olde mice. BSO is a compound ha seems o be
e icien o induce oxida i e s ess only on ce ain animal mod-
els such as guinea pigs, newbo n a s, o young mice (48).
Ou esul s p o ide clea e idence ha he impai men o
he mine aloco icoid biological esponse is co ela ed wi h an
inc eased con en o issue MDA, a high ca bonyla ion le el o
MR and EF-2, and a dec eased amoun o biologically ac i e
EF-2 (as de e mined by i s low ADP- ibosyla able le el). In e -
es ingly, no all p o eins a e a ec ed by oxida i e s ess o an
equi alen ex en . Thus, he concen a ion o hsp90 was
g ea ly inc eased, whe eas enal
␤
- ubulin emained un-
changed a e he ea men wi h BSO (Fig. 2). In a p e ious
wo k (14), we ha e also analyzed he ac i i y o se e al p o eins
ela ed o he mechanism o ac ion o MR, such as ci a e
syn hase, 11
␤
-hyd oxys e oid dehyd ogenase, Na
⫹
/H
⫹
an i-
po , and Na
⫹
/K
⫹
-ATPase. The e we e no d ama ic changes in
any o hese p o eins. Mo eo e , he Na
⫹
/K
⫹
-ATPase ac i i y
seems o be p ese ed due o an inc eased numbe o ac i e
pumps, so ha a dec eased speci ic ac i i y o he Na
⫹
/K
⫹
-
ATPase pumps was in e ed om hese obse a ions. Oxida-
i e s ess is in insically associa ed wi h a s a e o inc eased
u no e o biomolecules induced by ele a ed a es o eac i e
oxygen species. Howe e , ex ensi e s udies ha e ecen ly dem-
ons a ed ha o he p o eins also inc ease hei ac i i y upon
oxida i e s ess in a signi ican manne , o example c-Jun
NH
2
- e minal kinase (49), p70-S6 kinase (50), Ak /PKB (51),
glucose-6-phospha e dehyd ogenase (52), PDK1 (53), and SGK
(54), among many o he examples. In e es ingly, he las wo
p o eins a e ela ed o he mine aloco icoid biological e-
sponse. Thus, he se um- and glucoco icoid-dependen kinase
(SGK) has been linked o he ALDO-dependen mechanism o
ac i a ion o he epi helial sodium channel (55, 56). In u n,
he e exis s subs an ial e idence showing ha SGK is egu-
la ed by he phosphoinosi ide-dependen kinase 1, PDK1.
The e o e, i seems ha he e also exis se e al egula o y
mechanisms ha a e simul aneously igge ed by oxida i e
s ess, so ha such a compensa o y egula ion a enua es dam-
aging e ec s like hose e idenced he e o he MR-media ed
biological esponse and he ansla ion machine y.
On he o he hand, aging is ela ed o a dec ease in he s ess
esponse and he loss o a low edox po en ial milieu (22, 57). I
has been epo ed ecen ly (25) ha oxida i e s ess induced by
xenobio ics dec ease p o ein syn hesis, as his e ec is due o a
dec eased e iciency in he elonga ion s ep du ing he ansla-
ion p ocess. Simila conclusions we e eached when aging-
ela ed e ec s we e also compa ed wi h ee adical damage
(34). Because he ALDO binding capaci y o enal MR de-
FIG.5.Poly ibosomal p o iles and polypep ide comple ion ime in kidney. A suc ose g adien o enal polysomes was pe o med a e
30-day-old mice we e ea ed unde he ollowing condi ions (polysomes/monome s a ios a e gi en in pa en heses). A, un ea ed con ols (solid
line) (13); mice ea ed wi h BSO o 3 days (dashed line) (40), o 10 days (do ed line) (59). B, un ea ed 30-day-old con ols (solid line) (13),
un ea ed 18-mon h-old mice (dashed line) (47); 30-day-old mice co- ea ed wi h GME and BSO o 10 days (do ed line) (12). C,[
3
H] aline
inco po a ed in o enal Pn and P was measu ed in 30-day-old mice ea ed o 10 days wi h ei he ehicle (black ci cles) o BSO (whi e ci cles).
The Pn/P a io o un ea ed 18-mon h-old mice is also shown (black squa es). The comple ion ime was calcula ed om he slope o each unc ion.
The poin s ep esen he means ⫾S.E. o ou mice.
FIG.6.Oxida i e damage o enal MR and EF-2. A, p o ein ca bonyla ion and ADP- ibosyla ion o immunopu i ied EF-2. Thi y-day-old
mice we e ea ed o 10 days wi h BSO o GME and BSO. The ca bonyl g oup con en o MR and EF-2 and he ADP- ibosyla able le el we e
measu ed in immunopu i ied samples. The same pa ame e s we e also measu ed in immune pelle s ob ained om un ea ed 18-mon h-old mice.
Ba s ep esen he means ⫾S.E. (n⫽4) o ADP- ibosyla able EF-2 con en (ha ched ba s), ca bonyl g oups in EF-2 (black ba s), and he MR
(whi e ba s). Resul s a e p esen ed as a pe cen age o he alue measu ed in un ea ed 30-day-old animals (23.5 ⫾1.8 nmol o MDA/mg p o ein,
and 387 ⫾40 nmol and p o ein ca bonyls g oup/mg p o ein). Values a e signi ican ly di e en a *, p⬍0.005, and **, p⬍0.010. B, p o eoly ic
agmen a ion o enal EF-2. P o eins om enal cy osol we e esol ed by SDS-PAGE, and EF-2 was isualized by Wes e n blo ing. Condi ions
a e as ollows: 1, cy osol om 30-day-old mice; 2, cy osol om BSO- ea ed mice o 3 days; 3, cy osol om BSO- ea ed mice o 10 days; 4, cy osol
om mice co- ea ed wi h BSO and GME o 10 days; 5, cy osol o un ea ed 18-mon h-old mice. A ows on he igh side show molecula weigh
ma ke s. A ows on he le side show he ull-leng h EF-2 band and i s main deg ada ion p oduc s a 39, 51, and 67 kDa.
MR Inac i a ion by Oxida i e S ess11902
c eases wi h aging, and because he simila pa e n e idenced
in his wo k be ween he ha m ul e ec s o GSH deple ion and
aging, we may ce ainly specula e ha he cumula i e damage
gene a ed along he li e ime by oxida i e s ess may a ec
enal cells (and o he issues as well) in a simila manne as
ha desc ibed he e o mice ea ed wi h BSO. None heless, a
key conund um such as whe he o no p o ein damaging is
p ima y o seconda y in aging s ill emains o be answe ed.
I is easonable o s a e ha he ex en o any ype o oxida-
i e s ess mus be exace ba ed by a dec eased e iciency in he
na u al an ioxidan compounds. In es iga ion o he GSH en-
zyma ic sys em in pa ien s wi h ch onic enal ailu e has e-
ealed ha he ac i i ies o GSH pe oxidase and GSH educ-
ase as well as he plasma GSH concen a ion we e
signi ican ly educed (15). Consis en wi h he p edominan
syn hesis o GSH pe oxidase in he enal ubule, a d ama ic
dec ease in plasma enzyma ic ac i i y was also obse ed. De-
ple ion o GSH can also con ibu e o enal dys unc ion because
his hiol is no only an e icien adical sca enge bu is also an
impo an de oxican o elimina ing di e en elec ophilic
compounds o exogenous and endogenous o igin ia glu a hione
S- ans e ase ac i i y. The e o e, GSH de iciency may con ib-
u e o he accumula ion o ha m ul compounds.
In summa y, he molecula indings p esen ed in his wo k
con ibu e o an eme ging pic u e ha shows a dec eased enal
MR-dependen biological esponse as a consequence o he de-
ple ion o he GSH an ioxidan sys em. This ailu e is linked o
bo h pos - ansla ional modi ica ion o he ecep o p o ein and
impai ed polypep ide syn hesis. These indings may be ela ed
o he undesi ed kidney dys unc ion obse ed du ing no mal
aging and ce ain pa hological condi ions.
Acknowledgmen —We a e indeb ed o D . R. E ans o he kind
p o ision o ecombinan DNA encoding o human MR.
REFERENCES
1. P a , W. B., and To , D. O. (1997) Endoc . Re . 18, 306–360
2. Galigniana, M. D. (2000) Cu . Top. S e oid Res. 3, 1–22
3. Galigniana, M. D. (1998) Biochem. J. 333, 555–563
4. Galigniana, M. D., Housley, P. R., DeF anco, D. B., and P a , W. B. (1999)
J. Biol. Chem. 274, 16222–16227
5. Galigniana, M. D., Housley, P. R., Sc uggs, J. L., He ing on, M. J., Welsh,
M. J., Ca e -Su, C., and P a , W. B. (1998) Mol. Endoc inol. 12,
1903–1913
6. DeF anco, D. M., Qi, M., Bo o , K., and B au igan, D. L. (1991) Mol. Endo-
c inol. 5, 1215–1229
7. Piwien-Pilipuk, G., and Galigniana, M. D. (1998) Mol. Cell. Endoc inol. 144,
119–130
8. Sil e s ein, A. M., Galigniana, M. D. Kanelakis, K. C., Radanyi, C., Renoi ,
J. M., and P a , W. B. (1999) J. Biol. Chem. 274, 36980–36986
9. Galigniana, M. D., Radanyi, C., Renoi , J. M., Housley, P. R., and P a , W. B.
(2001) J. Biol. Chem. 276, 14884–14889
10. Galigniana, M. D. (1996) Li e Sci. 59, 511–521
11. Souque, A., Faga , B., Cou e, M. E., Ra es in-Oblin, M. E. (1996) J. S e oid
Biochem. Mol. Biol. 57, 315–321
12. Lupo, D., Mesnie , G., and Auzou, G. (1998) Biochemis y 37, 12153–12159
13. Galigniana, M. D., and Piwien-Pilipuk, G. (1999) Biochem. J. 341, 585–592
14. Piwien-Pilipuk, G., and Galigniana, M. D. (2000) Biochim. Biophys. Ac a 1495,
263–280
15. Ceballos-Pico , I., Wi ko-Sa sa , V., Me ad-Boudia, M., Nguyen, A. T.,
The´ enin, M., Jaudon, M. C., Zing a , J., Ve ge , C., Junge s, P., and
Descamps-La scha, B. (1996) F ee Radic. Biol. Med. 21, 845–853
16. Na h, K. A., and Salahudeen, A. K. (1990) J. Clin. In es . 86, 1179–1192
17. Yoshioka, T., Bills, T., Moo e-Ja e , T., G eene, H. L., Bu , I. M., and
Ichikawa, I. (1990) Kidney In . 38, 282–288
18. Baud, L., and A caillou, R. (1986) Am. J. Physiol. 20, F765–F776
19. Himmel a b, J., Aul , K. A., Holb ook, D., Leebe , D. A., and Hakim, R. M.
(1993) J. Am. Soc. Neph ol. 4, 178–186
20. Dasgup a, A., Hussain, S., and Ahmad, S. (1992) Neph on 60, 56–59
21. S adman, E. R. (1992) Science 257, 1220–1224
22. Dean, R. T., Fu, S., S ocke , R., and Da ies, M. J. (1997) Biochem. J. 324, 1–18
23. Me ke , K., Si e, N., and G une, T. (2000) A ch. Biochem. Biophys. 375, 50–54
24. A iza, J. L., Weinbe ge , C., Ce elli, G., Glase , T. M., Handelin, B. L.,
Housman, D. E., and E ans, R. M. (1987) Science 237, 268–275
25. Ayala, A., Pa ado, J., Boug ia, M., and Machado, A. (1996) J. Biol. Chem. 271,
23105–23110
26. Robe son, N. M., Schulman, G., Ka nik, S., Alnem i, E., and Li wack, G.
(1993) Mol. Endoc inol. 7, 1226–1239
27. Bu on, G., Galigniana, M. D., deLa allaz, S., B ache -Co a, A., Sp o ie o, E.,
Ghini, A., and Lan os, C. P. (1995) Mol. Pha macol. 47, 535–543
28. Galigniana, M. D., Vicen , G. P., Piwien-Pilipuk, G., Bu on, G., and Lan os,
C. P. (2000) Mol. Pha macol. 58, 58–70
29. Galicka, A., S edzinska, K., and Gindzienski, A. (2000) Biochem. Biophys. Res.
Commun. 269, 553–556
30. Ryazano , A. G., and Da ydo a, E. K. (1989) FEBS Le . 251, 187–190
31. Da ydo a, E., Malinin, N. L., and O chinniko , L. P. (1993) Eu . J. Biochem.
215, 291–296
32. Lenz, A.-G., Cos abel, U., Shal iel, S., and Le ine, R. L. (1989) Anal. Biochem.
177, 419–425
33. Es e baue H., and Cheeseman K. H. (1990) Me hods Enzymol. 186, 407–413
34. Pa ado, J., Boug ia, M., Ayala, A., Cas an˜o, A., and Machado, A. (1999) F ee
Radic. Biol. Med. 26, 362–370
35. Tama i , J., Cabiscol, E., and Ros, J. (1997) J. Biol. Chem. 271, 3027–3032
36. Ta e, B. G., Takahashi, N., Kensle , T. W., and Manson, R. P. (1987) J. Biol.
Chem. 262, 12143–12149
37. Quian, M. Q., Tang, P. L., and Mo gan, E. H. (1996) Biochim. Biophys. Ac a
1310, 293–302
38. Henshaw, E. C. Guiney, D. G., and Hi sch, C. A. (1973) J. Biol. Chem. 248,
4367–4376
39. Howa d, G. A., Adamson, S. D., and He be , E. (1970) J. Biol. Chem. 245,
6237–6239
40. Kaba , D., and Rich, A. (1969) Biochemis y 8, 3743–3749
41. Hoe , W., and McCa y, K. S. (1969) P oc. Na l. Acad. Sci. U. S. A. 63,
1206–1213
42. Fal ey, A. K., and S aehelin, T. (1970) J. Mol. Biol. 53, 21–34
43. Smulson, M. E., and Rideau, C. (1970) J. Biol. Chem. 245, 5350–5360
44. Weissbach, H., and Ochoa, S. (1976) Annu. Re . Biochem. 45, 191–216
45. Riis, B., Ra an, S. I. S., Ca allius, J., and Cla k, B. F. C. (1989) Biochem.
Biophys. Res. Commun. 159, 1141–1146
46. Ayuso-Pa illa, M. S., Ma ı´n-Reque o, A., Pe´ ez-Dı´az, J., and Pa illa, R.
(1976) J. Biol. Chem. 251, 7785–7790
47. Sco nik, O. A. (1974) J. Biol. Chem. 249, 3876–3883
48. Meis e , A. (1991) Pha macol. The . 51, 155–194
49. Lo, Y. Y. C., Wong, J. M. S., and C uz, T. F. (1996) J. Biol. Chem. 271,
15073–15707
50. Bae, G.-U., Seo, D.-W., Kwon, H. K., Lee, H. Y., Hong, S., Lee, Z. W., Ha, K. S.,
and Han, J. W. (1999) J. Biol. Chem. 274, 32596–32602
51. Shaw, M., Cohen, P., and Alessi, D. R. (1998) Biochem. J. 336, 241–246
52. P e` ille, X., Sal emini, F., Gi aud, S., Chau ou , S., Paul, C., S epien, G.,
U sini, M. V., and A igo, A. P. (1999) Exp. Cell Res. 247, 61–78
53. P assad, N., Topping, R. S., Zhou, D., and Decke , S. J. (2000) Biochemis y 39,
6929–6935
54. Kobayashi, T., and Cohen, P. (1999) Biochem. J. 339, 319–328
55. Bha ga a, A., Fulle on, M. J., Myles, K., Pu dy, T. M., Funde , J. W., Pea ce,
D., and Cole, T. (2001) Endoc inology 142, 1587–1594
56. Pea ce, D. (2001) T ends Endoc inol. Me ab. 12, 341–347
57. Ve beke, P., Fonage , J., Cla k, B. F. C., and Ra an, S. I. (2001) Cell Biol. In .
25, 845–857
MR Inac i a ion by Oxida i e S ess 11903